共 128 条
[1]
Loibl S(2021)Breast cancer Lancet 397 1750-250
[2]
Poortmans P(2020)Advanced approaches to breast cancer classification and diagnosis Front Pharmacol 11 632079-62
[3]
Morrow M(2020)Towards personalized treatment for early stage HER2-positive breast cancer Nat Rev Clin Oncol 17 233-128
[4]
Denkert C(2011)HER2: biology, detection, and clinical implications Arch Pathol Lab Med 135 55-30
[5]
Curigliano G(2019)HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance Ther Adv Med Oncol 11 1758835919833519-366
[6]
Zubair M(2015)Targeting HER2 for the treatment of breast cancer Annu Rev Med 66 111-1327
[7]
Wang S(2015)Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 26 v8-1594
[8]
Ali N(2018)Herceptin(R) (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis Syst Rev 7 191-39
[9]
Goutsouliak K(2019)Recognizing radiation therapy-related complications in the chest Radiographics 39 344-117
[10]
Veeraraghavan J(2020)Assessment of immune-related interstitial lung disease in patients with NSCLC treated with immune checkpoint inhibitors: a multicenter prospective study J Thorac Oncol 15 1317-720